Theoretical pharmacokinetic advantages and methodological flaws : glargine is not superior to NPH insulin in children with type 1 diabetes mellitus

dc.contributor.author	Dora, José Miguel Silva	pt_BR
dc.contributor.author	Scheffel, Rafael Selbach	pt_BR
dc.date.accessioned	2012-05-03T01:26:17Z	pt_BR
dc.date.issued	2010	pt_BR
dc.identifier.issn	0004-2730	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/40073	pt_BR
dc.format.mimetype	application/pdf	pt_BR
dc.language.iso	eng	pt_BR
dc.relation.ispartof	Arquivos brasileiros de endocrinologia & metabologia = Brazilian archives of endocrinology and metabolism. Vol. 54, n. 1 (fev. 2010), p. 82-84	pt_BR
dc.rights	Open Access	en
dc.subject	Farmacocinética	pt_BR
dc.subject	Insulina isofana	pt_BR
dc.subject	Criança	pt_BR
dc.subject	Métodos	pt_BR
dc.subject	Complicações do diabetes	pt_BR
dc.subject	Diabetes mellitus tipo 1	pt_BR
dc.title	Theoretical pharmacokinetic advantages and methodological flaws : glargine is not superior to NPH insulin in children with type 1 diabetes mellitus	pt_BR
dc.type	Artigo de periódico	pt_BR
dc.identifier.nrb	000755443	pt_BR
dc.type.origin	Nacional	pt_BR

Este item está licenciado na Creative Commons License